Dana-Farber Cancer Institute
S

ESMO 2021 Update on T-DXd +/- Pertuzumab vs. THP in 1L HER2+ MBC: DESTINY-Breast09

By Dana-Farber Cancer Institute FEATURING Sara Tolaney
By Dana-Farber Cancer Institute FEATURING Sara Tolaney
334 views
September 28, 2021
Comments 0
Login to view comments. Click here to Login

Related Videos

Total Health

Oncology Clinical Updates - Review and Renew

Sat, Apr 5, 2025
08:05

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

2.6K views
08:35

Year in Review 2024: Top Metastatic Breast Cancer Trials

Oncology 2024 Year in Review

V. Kaklamani

1.9K views
06:51

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

1.5K views
21:18

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

2024 SABCS Annual Meeting Insights Hub

M. Gatti-Mays

1.1K views
25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

5.4K views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

1.6K views
14:36

SABCS 2024 Insights: PATINA - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

696 views
08:49

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

1.5K views
05:56

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

2024 SABCS Annual Meeting Insights Hub

A. Brufsky

618 views
21:34

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

Shabnam Jaffer

1.1K views
17:56

New

Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC fo…

2024 SABCS Annual Meeting Insights Hub

S. Hurvitz

356 views
25:14

SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Pre…

2024 SABCS Annual Meeting Insights Hub

L. van ’t Veer

461 views
20:25

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

739 views
04:03

Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in m…

Fernanda Mosele

587 views
15:25

Evolution of Treatment Algorithms for HER2+ mBC

RWJBarnabas Health Rutgers Cancer Institute of New Jersey

M. George

567 views
29:24

ESMO 2024 Summary: Breast Cancer Highlights - AURORA Program, DAISY …

2024 ESMO Annual Meeting Insights Hub

C. Sotiriou

745 views
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

779 views
20:32

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Bre…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

583 views
20:08

New

FDA Approval Clinical Implications: Dato-DXd for Unresectable or Met…

UCSF School of Medicine

H. Rugo

192 views
08:33

New

Targeted ADCs Beyond HER2 in Breast Cancer Treatment

Yale Cancer Center

I. Krop

198 views
AUTOPLAY